|
US5786464C1
(en)
*
|
1994-09-19 |
2012-04-24 |
Gen Hospital Corp |
Overexpression of mammalian and viral proteins
|
|
US5876995A
(en)
|
1996-02-06 |
1999-03-02 |
Bryan; Bruce |
Bioluminescent novelty items
|
|
US6247995B1
(en)
|
1996-02-06 |
2001-06-19 |
Bruce Bryan |
Bioluminescent novelty items
|
|
US6534312B1
(en)
|
1996-02-22 |
2003-03-18 |
Merck & Co., Inc. |
Vaccines comprising synthetic genes
|
|
GB9611981D0
(en)
*
|
1996-06-07 |
1996-08-07 |
Zeneca Ltd |
Enhancement of gene expression
|
|
AU728422B2
(en)
*
|
1996-06-21 |
2001-01-11 |
Merck & Co., Inc. |
Vaccines comprising synthetic genes
|
|
US6416960B1
(en)
|
1996-08-08 |
2002-07-09 |
Prolume, Ltd. |
Detection and visualization of neoplastic tissues and other tissues
|
|
US6124128A
(en)
|
1996-08-16 |
2000-09-26 |
The Regents Of The University Of California |
Long wavelength engineered fluorescent proteins
|
|
US6593135B2
(en)
|
1996-08-16 |
2003-07-15 |
The State Of Oregon, Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon |
Long wavelength engineered fluorescent proteins
|
|
US6114148C1
(en)
*
|
1996-09-20 |
2012-05-01 |
Gen Hospital Corp |
High level expression of proteins
|
|
ATE290205T1
(de)
|
1996-12-12 |
2005-03-15 |
Prolume Ltd |
Vorrichtung und verfahren zum nachweis und identifizieren von infektiösen wirkstoffen
|
|
US6696291B2
(en)
|
1997-02-07 |
2004-02-24 |
Merck & Co., Inc. |
Synthetic HIV gag genes
|
|
EE9900343A
(et)
*
|
1997-02-07 |
2000-02-15 |
Merck & Co., Inc. |
Sünteetiline polünukleotiid, immuunvastuste tekitamise meetod, immunogeenne kompositsioon, anti-HIV immuunvastuste indutseerimise meetod, meetod antigeeni tekitava raku indutseerimiseks ja farmatseutiline kompositsioon
|
|
US7105724B2
(en)
|
1997-04-04 |
2006-09-12 |
Board Of Regents Of University Of Nebraska |
Methods and materials for making and using transgenic dicamba-degrading organisms
|
|
RU2226215C2
(ru)
|
1997-04-04 |
2004-03-27 |
Борд Оф Риджентс Оф Юниверсити Оф Нибраска |
Молекула днк, кодирующая дикамба-разрушающую оксигеназу, и ее применение
|
|
AUPP807899A0
(en)
|
1999-01-08 |
1999-02-04 |
University Of Queensland, The |
Codon utilization
|
|
US6602677B1
(en)
*
|
1997-09-19 |
2003-08-05 |
Promega Corporation |
Thermostable luciferases and methods of production
|
|
US6593463B1
(en)
*
|
1997-10-20 |
2003-07-15 |
Genzyme Transgenics Corporation |
Modified MSP-1 nucleic acid sequences and methods for increasing MRNA levels and protein expression in cell systems
|
|
GB9803351D0
(en)
*
|
1998-02-17 |
1998-04-15 |
Oxford Biomedica Ltd |
Anti-viral vectors
|
|
US6683230B1
(en)
|
1998-02-20 |
2004-01-27 |
Syngenta Limited |
Hybrid seed production
|
|
US6924365B1
(en)
|
1998-09-29 |
2005-08-02 |
Transkaryotic Therapies, Inc. |
Optimized messenger RNA
|
|
US20090042283A1
(en)
*
|
1998-09-29 |
2009-02-12 |
Shire Human Genetic Therapies, Inc., A Delaware Corporation |
Optimized messenger rna
|
|
EP1010763A1
(de)
*
|
1998-12-11 |
2000-06-21 |
Institut Pasteur |
Verstärkte Expression von heterologen Proteine in rekombinanten Bakterien durch erniedrigter Wachstemperatur und Co-expression von seltenen tRNA's
|
|
ATE384795T1
(de)
|
1998-12-31 |
2008-02-15 |
Novartis Vaccines & Diagnostic |
Modifizierte hiv env polypeptide
|
|
EP1141314A2
(de)
*
|
1998-12-31 |
2001-10-10 |
Chiron Corporation |
Für antigene polypeptide des hiv type c kodierende polynukleotide, entsprechende polypeptide und verwendungen davon
|
|
AU2221600A
(en)
|
1998-12-31 |
2000-07-31 |
Chiron Corporation |
Improved expression of hiv polypeptides and production of virus-like particles
|
|
US7935805B1
(en)
*
|
1998-12-31 |
2011-05-03 |
Novartis Vaccines & Diagnostics, Inc |
Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
|
|
WO2000029561A2
(en)
|
1999-03-29 |
2000-05-25 |
Statens Serum Institut |
Nucleotide construct with optimised codons for an hiv genetic vaccine based on a primary, early hiv isolate and synthetic envelope
|
|
US20050005310A1
(en)
*
|
1999-07-12 |
2005-01-06 |
Genentech, Inc. |
Expression vectors and methods
|
|
US6716614B1
(en)
*
|
1999-09-02 |
2004-04-06 |
Lexicon Genetics Incorporated |
Human calcium dependent proteases, polynucleotides encoding the same, and uses thereof
|
|
US6541252B1
(en)
|
2000-05-19 |
2003-04-01 |
Lexicon Genetics Incorporated |
Human kinases and polynucleotides encoding the same
|
|
US20030096778A1
(en)
*
|
2002-06-13 |
2003-05-22 |
Shiver John W |
Polynucleotide vaccines expressing codon optimized hiv-1 nef and modified hiv-1 nef
|
|
US20040063653A1
(en)
*
|
2000-12-21 |
2004-04-01 |
Shiver John W. |
Polynucleotide vaccines expressing codon optimized hiv-1 pol and modified hiv-1 pol
|
|
US6656706B2
(en)
*
|
1999-12-23 |
2003-12-02 |
The United States Of America As Represented By The Department Of Health And Human Services |
Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes
|
|
CA2400642A1
(en)
*
|
2000-02-23 |
2001-08-30 |
Vertex Pharmaceuticals (San Diego) Llc |
Modified fluorescent proteins
|
|
US6502774B1
(en)
*
|
2000-03-08 |
2003-01-07 |
J + L Fiber Services, Inc. |
Refiner disk sensor and sensor refiner disk
|
|
AU2002224555A1
(en)
*
|
2000-07-25 |
2002-02-05 |
Takeda Chemical Industries Ltd. |
Process for producing recombinant protein
|
|
US20030157643A1
(en)
*
|
2000-08-24 |
2003-08-21 |
Almond Brian D |
Synthetic nucleic acids from aquatic species
|
|
US7879540B1
(en)
|
2000-08-24 |
2011-02-01 |
Promega Corporation |
Synthetic nucleic acid molecule compositions and methods of preparation
|
|
AU2000268170A1
(en)
*
|
2000-09-04 |
2002-03-22 |
Hunan Royal Biotech |
A cell line expressing mutant human tissue-type plasminogen activator, constructing strategy and method of expressed protein preparation
|
|
US7122180B2
(en)
*
|
2000-10-23 |
2006-10-17 |
Children's Medical Center Corporation |
DNA vectors containing mutated HIV proviruses
|
|
EP1330524A2
(de)
*
|
2000-10-30 |
2003-07-30 |
Lexicon Genetics Incorporated |
Humane 7tm-proteine und dafür kodierende polynukleotiden
|
|
JP3929250B2
(ja)
*
|
2001-03-08 |
2007-06-13 |
株式会社ルネサステクノロジ |
半導体装置
|
|
ATE291925T1
(de)
*
|
2001-06-05 |
2005-04-15 |
Curevac Gmbh |
Stabilisierte mrna mit erhöhtem g/c-gehalt und optimierter codon usage für die gentherapie
|
|
JP3829252B2
(ja)
*
|
2001-06-08 |
2006-10-04 |
独立行政法人理化学研究所 |
蛍光蛋白質
|
|
US6780974B2
(en)
*
|
2001-06-12 |
2004-08-24 |
Cellomics, Inc. |
Synthetic DNA encoding an orange seapen-derived green fluorescent protein with codon preference of mammalian expression systems and biosensors
|
|
US6943001B2
(en)
*
|
2001-08-03 |
2005-09-13 |
Diversa Corporation |
Epoxide hydrolases, nucleic acids encoding them and methods for making and using them
|
|
CA2456229A1
(en)
*
|
2001-08-03 |
2003-02-13 |
Diversa Corporation |
Epoxide hydrolases, nucleic acids encoding them and methods for making and using them
|
|
CA2458995C
(en)
*
|
2001-08-31 |
2013-04-30 |
Chiron Corporation |
Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
|
|
WO2003054158A2
(en)
*
|
2001-12-19 |
2003-07-03 |
The University Of Chicago |
Rapidly maturing fluorescent proteins and methods for using the same
|
|
EP1478656B1
(de)
|
2002-02-01 |
2009-09-16 |
Life Technologies Corporation |
Oligonukleotidzusammensetzungen mit verbesserter effizienz
|
|
US20030166282A1
(en)
|
2002-02-01 |
2003-09-04 |
David Brown |
High potency siRNAS for reducing the expression of target genes
|
|
US20060009409A1
(en)
|
2002-02-01 |
2006-01-12 |
Woolf Tod M |
Double-stranded oligonucleotides
|
|
US7226771B2
(en)
|
2002-04-19 |
2007-06-05 |
Diversa Corporation |
Phospholipases, nucleic acids encoding them and methods for making and using them
|
|
EP1497418B1
(de)
|
2002-04-19 |
2012-10-17 |
Verenium Corporation |
Phospholipasen, diese codierende nukleinsäuren sowie verfahren zu ihrer herstellung und verwendung
|
|
MXPA04012614A
(es)
|
2002-06-14 |
2005-12-14 |
Diversa Corp |
Xilanasas, acidos nucleicos que las codifican, y metodos para hacerlas y usarlas.
|
|
US20040166567A1
(en)
*
|
2002-09-26 |
2004-08-26 |
Santi Daniel V |
Synthetic genes
|
|
AU2003275776B2
(en)
*
|
2002-11-08 |
2009-06-18 |
Jingang Medicine (Australia) Pty Ltd |
A method for optimising gene expression using synonymous codon optimisation
|
|
CA2505974A1
(en)
|
2002-11-12 |
2004-05-27 |
Zakrytoe Aktsionernoe Obschestvo "Evrogen" |
Fluorescent proteins and chromoproteins from non-aequorea hydrozoa species and methods for using same
|
|
US20050019925A1
(en)
*
|
2002-11-14 |
2005-01-27 |
Genentech, Inc. |
Intron fusion construct and method of using for selecting high-expressing production cell lines
|
|
US7413874B2
(en)
*
|
2002-12-09 |
2008-08-19 |
University Of Miami |
Nucleic acid encoding fluorescent proteins from aquatic species
|
|
WO2004058166A2
(en)
*
|
2002-12-23 |
2004-07-15 |
Vical Incorporated |
Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection
|
|
CA2510884A1
(en)
|
2002-12-26 |
2004-07-15 |
Zakrytoe Aktsionernoe Obschestvo "Evrogen" |
Fluorescent proteins from copepoda species and methods for using same
|
|
EP2194133B1
(de)
|
2003-03-06 |
2015-12-02 |
BASF Enzymes LLC |
Amylasen, Nukleinsäuren, die diese codieren, und Verfahren zu deren Herstellung und Verwendung
|
|
CA2515583C
(en)
|
2003-03-07 |
2015-07-14 |
Diversa Corporation |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
|
EP1613733B1
(de)
|
2003-04-04 |
2015-06-03 |
BASF Enzymes LLC |
Pektatlyasen, diese codierende nukleinsäuren und verfahren zu deren herstellung und verwendung
|
|
EP1622937A2
(de)
*
|
2003-05-05 |
2006-02-08 |
Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. |
Synthetisches gen, das für humaes carcinoembryonisches antigen codiert, und verwendungen dafür
|
|
CN103484486B
(zh)
|
2003-07-02 |
2018-04-24 |
维莱尼姆公司 |
葡聚糖酶,编码它们的核酸以及制备和使用它们的方法
|
|
US7741089B2
(en)
|
2003-08-11 |
2010-06-22 |
Verenium Corporation |
Laccases, nucleic acids encoding them and methods for making and using them
|
|
EP1732944B1
(de)
|
2004-04-07 |
2012-09-05 |
The University of Chicago |
Monomere, rotfluoreszierende proteine
|
|
AU2005250477A1
(en)
*
|
2004-06-04 |
2005-12-15 |
Wyeth |
Enhancing protein expression
|
|
AU2005264938B2
(en)
|
2004-06-16 |
2011-11-24 |
Verenium Corporation |
Compositions and methods for enzymatic decolorization of chlorophyll
|
|
US7728118B2
(en)
*
|
2004-09-17 |
2010-06-01 |
Promega Corporation |
Synthetic nucleic acid molecule compositions and methods of preparation
|
|
WO2006049777A2
(en)
*
|
2004-09-30 |
2006-05-11 |
Trustees Of Dartmouth College |
Nucleic acid sequences encoding luciferase for expression in filamentous fungi
|
|
DK2410048T3
(en)
|
2005-01-24 |
2016-11-28 |
Dsm Ip Assets Bv |
A process for the preparation of a compound of interest in a filamentous fungal cell
|
|
EP1869174B1
(de)
|
2005-03-10 |
2015-02-18 |
BASF Enzymes LLC |
Lyase-enzyme, nukleinsäuren zu deren kodierung und verfahren zu deren herstellung und verwendung
|
|
EA018577B1
(ru)
|
2005-03-15 |
2013-09-30 |
Верениум Корпорейшн |
Целлюлазы, нуклеиновые кислоты, кодирующие их, и способы их получения и применения
|
|
WO2008036060A2
(en)
|
2005-04-05 |
2008-03-27 |
Allergan, Inc. |
Clostridial toxin activity assays
|
|
US8202523B2
(en)
*
|
2005-09-22 |
2012-06-19 |
ProSci, Inc. |
Glycosylated polypeptides produced in yeast mutants and methods of use thereof
|
|
EP1954713B1
(de)
*
|
2005-11-04 |
2012-11-14 |
Evrogen, JSC |
Modifizierte grünfluoreszierende proteine und verfahren zu deren anwendung
|
|
WO2007085923A2
(en)
|
2006-01-25 |
2007-08-02 |
Evrogen, Ip |
Novel fluorescent proteins and methods for using same
|
|
US8563703B2
(en)
|
2006-01-25 |
2013-10-22 |
Evrogen IP Joint Stock Company |
Fluorescent proteins and methods for using same
|
|
EP1987142A4
(de)
|
2006-02-02 |
2009-07-15 |
Verenium Corp |
Esterasen und damit zusammenhängende nukleinsäuren und verfahren
|
|
NZ595502A
(en)
|
2006-02-10 |
2013-11-29 |
Verenium Corp |
Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them
|
|
ES2682284T3
(es)
|
2006-02-14 |
2018-09-19 |
Bp Corporation North America Inc. |
Xilanasas, ácidos nucleicos que las codifican y métodos para elaborarlas y usarlas
|
|
ES2416104T3
(es)
|
2006-03-07 |
2013-07-30 |
Cargill, Incorporated |
Aldolasas, ácidos nucleicos que las codifican y métodos para producir y usar las mismas
|
|
KR101622894B1
(ko)
|
2006-03-07 |
2016-05-19 |
바스프 엔자임스 엘엘씨 |
알돌라제, 이것을 코딩하는 핵산과 그 제조 방법 및 사용 방법
|
|
US7855326B2
(en)
|
2006-06-06 |
2010-12-21 |
Monsanto Technology Llc |
Methods for weed control using plants having dicamba-degrading enzymatic activity
|
|
CA2657975A1
(en)
|
2006-06-29 |
2008-01-03 |
Dsm Ip Assets B.V. |
A method for achieving improved polypeptide expression
|
|
US20080004410A1
(en)
*
|
2006-06-30 |
2008-01-03 |
Yu-Chin Lai |
Hydrophilic macromonomers having alpha,beta-conjugated carboxylic terminal group and medical devices incorporating same
|
|
CN106222185B
(zh)
|
2006-08-04 |
2021-12-03 |
维莱尼姆公司 |
葡聚糖酶、编码它们的核酸及制备和使用它们的方法
|
|
EP2057274B1
(de)
|
2006-09-21 |
2013-12-11 |
DSM IP Assets B.V. |
Phospholipase ,nukleinsaüre, die diese kodieren und verfahren zur ihrer herstellung und verwendung
|
|
US8877478B2
(en)
|
2006-09-21 |
2014-11-04 |
Verenium Corporation |
Phytases, nucleic acids encoding them and methods for making and using them
|
|
BRPI0717640A2
(pt)
|
2006-10-16 |
2013-11-12 |
Monsato Technology Llc |
Processo e composições para aumentar a saúde de plantas
|
|
PL3101128T3
(pl)
|
2006-12-21 |
2019-09-30 |
Basf Enzymes Llc |
Amylazy i glukoamylazy, kwasy nukleinowe kodujące te związki oraz sposoby wytwarzania tych związków oraz stosowania ich
|
|
CN104212822A
(zh)
|
2007-01-30 |
2014-12-17 |
Bp法人北美有限公司 |
用于处理木质纤维素的酶、编码它们的核酸及其制备和应用方法
|
|
US7838729B2
(en)
|
2007-02-26 |
2010-11-23 |
Monsanto Technology Llc |
Chloroplast transit peptides for efficient targeting of DMO and uses thereof
|
|
US9043994B2
(en)
*
|
2007-03-13 |
2015-06-02 |
Massachusetts Institute Of Technology |
Cre-lox based gene knockdown constructs and methods of use thereof
|
|
US20080248511A1
(en)
*
|
2007-03-26 |
2008-10-09 |
Promega Corporation |
Methods to quench light from optical reactions
|
|
NZ601191A
(en)
|
2007-10-03 |
2014-01-31 |
Verenium Corp |
Xylanases, nucleic acids encoding them and methods for making and using them
|
|
WO2009049350A1
(en)
*
|
2007-10-15 |
2009-04-23 |
The University Of Queensland |
Expression system for modulating an immune response
|
|
US8679749B2
(en)
*
|
2007-11-01 |
2014-03-25 |
The University Of Chicago |
Red fluorescent proteins with enhanced bacterial expression, increased brightness and reduced aggregation
|
|
CA2710922A1
(en)
|
2008-01-03 |
2009-07-16 |
Verenium Corporation |
Isomerases, nucleic acids encoding them and methods for making and using them
|
|
AU2008347234B2
(en)
|
2008-01-03 |
2015-05-28 |
Basf Enzymes Llc |
Transferases and oxidoreductases, nucleic acids encoding them and methods for making and using them
|
|
US7561972B1
(en)
|
2008-06-06 |
2009-07-14 |
Dna Twopointo, Inc. |
Synthetic nucleic acids for expression of encoded proteins
|
|
US7561973B1
(en)
|
2008-07-31 |
2009-07-14 |
Dna Twopointo, Inc. |
Methods for determining properties that affect an expression property value of polynucleotides in an expression system
|
|
US8126653B2
(en)
*
|
2008-07-31 |
2012-02-28 |
Dna Twopointo, Inc. |
Synthetic nucleic acids for expression of encoded proteins
|
|
US8401798B2
(en)
*
|
2008-06-06 |
2013-03-19 |
Dna Twopointo, Inc. |
Systems and methods for constructing frequency lookup tables for expression systems
|
|
US8357503B2
(en)
|
2008-08-29 |
2013-01-22 |
Bunge Oils, Inc. |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
|
US8153391B2
(en)
|
2008-08-29 |
2012-04-10 |
Bunge Oils, Inc. |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
|
US8198062B2
(en)
|
2008-08-29 |
2012-06-12 |
Dsm Ip Assets B.V. |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
|
TW201029662A
(en)
|
2008-12-19 |
2010-08-16 |
Glaxo Group Ltd |
Novel antigen binding proteins
|
|
JP5304275B2
(ja)
*
|
2009-01-29 |
2013-10-02 |
Jnc株式会社 |
アポクライティン−iiをコードするコドン最適化核酸およびその使用方法
|
|
HUE030948T2
(en)
|
2009-05-21 |
2017-06-28 |
Basf Enzymes Llc |
Phytases, nucleic acids and processes encoding them for their production and use
|
|
DK2462237T3
(da)
|
2009-08-06 |
2016-03-29 |
Cmc Icos Biolog Inc |
Fremgangsmåder til forbedring af rekombinant proteinekspression
|
|
UA111708C2
(uk)
|
2009-10-16 |
2016-06-10 |
Бандж Ойлз, Інк. |
Спосіб рафінування олії
|
|
UA109884C2
(uk)
|
2009-10-16 |
2015-10-26 |
|
Поліпептид, що має активність ферменту фосфатидилінозитол-специфічної фосфоліпази с, нуклеїнова кислота, що його кодує, та спосіб його виробництва і застосування
|
|
CA2787070A1
(en)
|
2010-01-28 |
2011-08-04 |
Ian Kirby |
Cd127 binding proteins
|
|
UA108227C2
(xx)
|
2010-03-03 |
2015-04-10 |
|
Антигензв'язуючий білок
|
|
US9795658B2
(en)
|
2010-04-20 |
2017-10-24 |
Admedus Vaccines Pty Ltd |
Expression system for modulating an immune response
|
|
AR081556A1
(es)
|
2010-06-03 |
2012-10-03 |
Glaxo Group Ltd |
Proteinas de union al antigeno humanizadas
|
|
US8987423B2
(en)
|
2010-07-22 |
2015-03-24 |
Glaxosmithkline Biologicals, S.A. |
MAGE antigen binding proteins
|
|
JP6224077B2
(ja)
|
2012-04-17 |
2017-11-01 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
改変された核酸を用いてポリペプチドを発現させるための方法
|
|
EP2844290A4
(de)
|
2012-05-01 |
2015-12-16 |
Glaxosmithkline Llc |
Neuartige antikörper
|
|
EP2850106B1
(de)
|
2012-05-18 |
2022-03-23 |
Aptevo Research and Development LLC |
Bispezifische scfv-immunofusion (bif) mit fähigkeit zur bindung von cd123 und cd3
|
|
US20150197760A1
(en)
|
2012-06-19 |
2015-07-16 |
Dsm Ip Assets B.V. |
Promoters for expressing a gene in a cell
|
|
CN105764526B
(zh)
|
2013-08-26 |
2020-12-15 |
生物技术研发公司 |
编码抗唾液酸化路易斯a抗原的人抗体的核酸
|
|
US9856324B2
(en)
|
2014-06-04 |
2018-01-02 |
MabVax Therapeutics, Inc. |
Human monoclonal antibodies to ganglioside GD2
|
|
WO2016059602A2
(en)
|
2014-10-16 |
2016-04-21 |
Glaxo Group Limited |
Methods of treating cancer and related compositions
|
|
WO2016186948A1
(en)
|
2015-05-15 |
2016-11-24 |
Albert Einstein College Of Medicine, Inc. |
Gfp-derived fusion tags for protein expression
|
|
EP3347486A4
(de)
|
2015-09-09 |
2019-06-19 |
The Trustees of Columbia University in the City of New York |
Reduktion von er-mam-lokalisierten app-c99 und verfahren zur behandlung der alzheimer-krankheit
|
|
WO2017201731A1
(en)
|
2016-05-27 |
2017-11-30 |
Beijing Vdjbio Co., Ltd. |
Antibodies, composition and kits comprising same, and methods of use thereof
|
|
US11707522B2
(en)
|
2017-10-13 |
2023-07-25 |
Boehringer Ingelheim International Gmbh |
Human antibodies to Tn antigen
|
|
RU2730038C2
(ru)
|
2018-06-28 |
2020-08-14 |
Общество с ограниченной ответственностью "ПЛАНТА" |
Ферменты биосинтеза люциферина и их применение
|
|
CA3106384A1
(en)
|
2018-11-02 |
2020-05-07 |
Beijing Vdjbio Co., Ltd. |
Modified ctla4 and methods of use thereof
|
|
BR112021025806A2
(pt)
|
2019-06-28 |
2022-02-08 |
Hoffmann La Roche |
Métodos para produzir um anticorpo da subclasse igg1 humana cultivando uma célula cho e uso da remoção de sítios de splice de doador não pareados em uma parte de uma sequência de ácido nucleico de humano ou hamster
|
|
TW202440647A
(zh)
|
2021-11-19 |
2024-10-16 |
英商米羅比奧有限公司 |
經工程改造之pd-1抗體及其用途
|
|
WO2023196866A1
(en)
|
2022-04-06 |
2023-10-12 |
Mirobio Limited |
Engineered cd200r antibodies and uses thereof
|